DIOPTRA+ONCOSCREEN Webinar | Bridging innovation and care: advancing colorectal cancer diagnosis technologies
In honour of #CRCAwarenessMonth, the EU-funded research projects ONCOSCREEN and DIOPTRA are delighted to invite you to another insightful webinar, where we will continue to shed light on the latest advancements in colorectal cancer diagnosis technology and raise awareness about this critical health concern.
Colorectal cancer continues to be a significant global health challenge, and through this webinar, we aim to bring together experts and researchers once again to share valuable insights, discuss innovative approaches, and foster collaboration in the fight against colorectal cancer.
Don't miss this opportunity to be part of a dynamic conversation that could shape the future of colorectal cancer awareness and research.
The webinar will take place on March 12, 10:30-11.55 CET
Save the date, mark your calendars, and register to engage in a meaningful dialogue that can make a difference in the battle against colorectal cancer.
Tickets
Additional Information
AGENDA
10:30 | Welcome and Introduction
10:35 | Opening Remarks from DIOPTRA and ONCOSCREEN management team
11:00 | Pedro Lopez, Machine Learning Engineer at EXUS, Dionysis Polyzos, Data Scientist and Software Engineer at Konnekt-able Technologies (video presentation) and Gerasimos Tzivras, Software Engineer at Konnekt-able Technologies: “From Risk to Action: ONCO-RISTE and ONCO-CLIDE as Collaborative Tools for Colorectal Cancer Diagnosis”
11:15 | Prof. Ioannis Papanikolau, MD, PhD, FEBGH, Attikon University General Hospital, University of Athens, Greece: “Innovations in Screenings: The Role of Biomarkers and Colonoscopy in Identifying Precancerous Lesions”
11:30 | Christos Androutsos, Software Engineer, University of Ioannina, Greece: “AI-Driven Innovations and Technological Advancements in Screening”
11:45 | Q&A
11:55 | Closing Remarks
Funded by the European Union.
This work has received funding from the Swiss State Secretariat for Education, Research and Innovation (SERI).
Funded by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant number 10056682].